28 Apr 2026 External Data and Cancer: the New Frontier That Could Transform Clinical Trials From Bocconi to the United States, a study in Biometrika proposes an innovative statistical method to make tests on new oncology drugs more effective and reliable
23 Feb 2026 The Limits of Transparency The Limits of Transparency Disclosing discounts and rebates does not lower drug prices. Without incentive-based interventions, regulation risks reallocating costs rather than eliminating them